FEBUXOSTAT (FEBUXOSTAT) — FDA Approval ANDA210292 (REGCON HOLDINGS)
FEBUXOSTAT (FEBUXOSTAT) — FDA Approval ANDA210292 (REGCON HOLDINGS) is one of 9,000 drug approvals in the DrugApprovals dataset. Key details — Brand name: FEBUXOSTAT; Active ingredients: FEBUXOSTAT; Application number: ANDA210292.
| Brand name | FEBUXOSTAT |
|---|---|
| Active ingredients | FEBUXOSTAT |
| Application number | ANDA210292 |
| Sponsor | REGCON HOLDINGS |
| Dosage form | TABLET |
| Route | ORAL |
| Marketing status | Prescription |
| Products in application | 2 |
| First approval date | 20191230 |
| Source | openFDA Drugs@FDA |
$1499/mo
Try DrugApprovals →